Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

Conclusion.Neoadjuvant therapy has clinical benefits in early breast cancer and provides in vivo information of individual breast cancer biology while allowing the investigation of new treatment approaches. Access to neoadjuvant therapy should be an option available to all patients with breast cancer through multidisciplinary tumor management.Implications for Practice.Neoadjuvant treatment should be strongly considered as a therapeutic option for localized breast cancer and is a powerful tool for understanding breast cancer biology and investigating new treatment approaches.

Source: The Oncologist - May 13, 2019 Category: Cancer & Oncology Authors: Ramon Colomer, Cristina Saura, Pedro Sanchez-Rovira, Tomas Pascual, Isabel T. Rubio, Octavio Burgues, Lourdes Marcos, Cesar A. Rodriguez, Miguel Martin, Ana Lluch Tags: Breast Cancer Source Type: research